Stay updated on Risankizumab vs Secukinumab in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website updates and says the agency is transitioning its terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T09:37:01.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The error page’s footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T12:22:47.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T12:31:39.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates that the study details are currently blocked from access.
    Difference
    18%
    Check dated 2026-09-19T18:42:12.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    A new line '2017 ( U.S. NIH Grant/Contract )' was added. The site revision was updated to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T18:46:03.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added, replacing the previous Revision: v3.6.4. This is a platform version update and does not change the study content on the page.
    Difference
    0.0%
    Check dated 2026-08-08T10:49:11.000Z thumbnail image

Stay in the know with updates to Risankizumab vs Secukinumab in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.